NervGen Pharma Corp. (TSXV:NGEN)
Canada
· Delayed Price · Currency is CAD 2.620
-0.020 (-0.76%)
Mar 28, 2025, 3:59 PM EST
NervGen Pharma Employees
NervGen Pharma had 7 employees as of December 31, 2019.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
202.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2019 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Green Thumb Industries | 4,800 |
| dentalcorp Holdings | 9,900 |
| Sienna Senior Living | 12,263 |
| WELL Health Technologies | 1,507 |
| Extendicare | 23,000 |
| Curaleaf Holdings | 5,519 |
| Trulieve Cannabis | 6,000 |
| Cronos Group | 459 |
NervGen Pharma News
- 6 days ago - NervGen Pharma to Host Virtual Investor Event - GlobeNewsWire
- 16 days ago - NervGen Pharma Grants Stock Options - Newsfile Corp
- 26 days ago - NervGen Pharma to Present at the Virtual Life Science Investor Forum - Newsfile Corp
- 5 weeks ago - NervGen Pharma Grants Stock Options - Newsfile Corp
- 7 weeks ago - NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury - Newsfile Corp
- 2 months ago - NervGen Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Newsfile Corp
- 2 months ago - NervGen In Spotlight As It Approaches Clinical Proof Of Concept Readout For Spinal Cord Regeneration - Seeking Alpha
- 3 months ago - NervGen Completes Enrollment in Chronic Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury - Newsfile Corp